Testing for myeloid differentiation factor 88 (MYD88) L265P mutation may be a useful tool in identifying chronic lymphocytic leukemia (CLL) in patients experiencing posterior uveitis, according...
A new analysis of patients with chronic lymphocytic leukemia (CLL) appears to confirm that the use of Bruton’s tyrosine kinase (BTK) inhibitors can increase the risk...
Cancer-related fatigue (CRF) unfortunately remains an unmet need: prevalent, underreported, poorly understood, and challenging to address. In conjunction with the Lymphoma Coalition, a quartet of researchers...
Lori A. Leslie, MD Director, Indolent lymphoma and Chronic Lymphocytic Leukemia Research Programs John Theurer Cancer Center Assistant Professor, Hackensack Meridian School of Medicine Hackensack, NJ...
Nakhle Saba, MD Associate Professor of Clinical Medicine Tulane University School of Medicine Tulane Cancer Center New Orleans, LA At a live virtual event, Nakhle Saba,...
In an interview with OncLive®, Sanjal Desai, MD, discussed the feasibility of venetoclax (Venclexta) rechallenge in patients with chronic lymphocytic leukemia (CLL) who progressed on prior...